Stryker Shares Outstanding 2010-2025 | SYK

Stryker shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Stryker shares outstanding for the quarter ending March 31, 2025 were 0.386B, a 0.34% increase year-over-year.
  • Stryker 2024 shares outstanding were 0.386B, a 0.5% increase from 2023.
  • Stryker 2023 shares outstanding were 0.384B, a 0.39% increase from 2022.
  • Stryker 2022 shares outstanding were 0.382B, a 0.03% decline from 2021.
Stryker Annual Shares Outstanding
(Millions of Shares)
2024 386
2023 384
2022 382
2021 382
2020 380
2019 380
2018 380
2017 380
2016 379
2015 381
2014 383
2013 382
2012 383
2011 390
2010 400
2009 399
Stryker Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 386
2024-12-31 386
2024-09-30 386
2024-06-30 385
2024-03-31 385
2023-12-31 384
2023-09-30 384
2023-06-30 384
2023-03-31 383
2022-12-31 382
2022-09-30 382
2022-06-30 382
2022-03-31 383
2021-12-31 382
2021-09-30 383
2021-06-30 382
2021-03-31 382
2020-12-31 380
2020-09-30 380
2020-06-30 376
2020-03-31 380
2019-12-31 380
2019-09-30 380
2019-06-30 380
2019-03-31 379
2018-12-31 380
2018-09-30 380
2018-06-30 380
2018-03-31 381
2017-12-31 380
2017-09-30 380
2017-06-30 380
2017-03-31 379
2016-12-31 379
2016-09-30 379
2016-06-30 379
2016-03-31 377
2015-12-31 381
2015-09-30 381
2015-06-30 381
2015-03-31 384
2014-12-31 383
2014-09-30 383
2014-06-30 383
2014-03-31 383
2013-12-31 382
2013-09-30 382
2013-06-30 381
2013-03-31 383
2012-12-31 383
2012-09-30 383
2012-06-30 383
2012-03-31 384
2011-12-31 390
2011-09-30 388
2011-06-30 392
2011-03-31 394
2010-12-31 400
2010-09-30 398
2010-06-30 399
2010-03-31 400
2009-12-31 399
2009-09-30 400
2009-06-30 399
2009-03-31 399
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $143.752B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.440B 27.47
Boston Scientific (BSX) United States $154.602B 38.70
EssilorLuxottica (ESLOY) France $130.179B 0.00
Medtronic (MDT) Ireland $103.476B 14.67
Haleon (HLN) United Kingdom $50.205B 28.56
Lonza Group Ag (LZAGY) Switzerland $49.251B 0.00
ResMed (RMD) United States $35.607B 26.74
GE HealthCare Technologies (GEHC) United States $31.667B 15.03
Agilent Technologies (A) United States $30.942B 20.44
Terumo (TRUMY) Japan $27.686B 35.96
Insulet (PODD) United States $22.616B 88.77
Koninklijke Philips (PHG) Netherlands $21.196B 15.24
Zimmer Biomet Holdings (ZBH) United States $18.329B 11.77
Baxter (BAX) United States $15.457B 11.54
Smith & Nephew SNATS (SNN) United Kingdom $12.539B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.090B 21.19
Lantheus Holdings (LNTH) United States $5.110B 12.89
Prestige Consumer Healthcare (PBH) United States $4.237B 18.93
Perrigo (PRGO) Ireland $3.651B 9.25
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.175B 23.41
Haemonetics (HAE) United States $3.173B 14.46
Envista Holdings (NVST) United States $2.834B 23.55
GN Store Nord (GNNDY) Denmark $2.054B 17.01
QuidelOrtho (QDEL) United States $2.011B 13.83
LeMaitre Vascular (LMAT) United States $1.839B 41.11
AtriCure (ATRC) United States $1.619B 0.00
Neogen (NEOG) United States $1.315B 16.83
Acuren (TIC) United States $1.272B 0.00
AdaptHealth (AHCO) United States $1.185B 12.03
Green Thumb Industries (GTBIF) United States $1.145B 25.76
Kestra Medical Technologies (KMTS) United States $1.139B 0.00
BioLife Solutions (BLFS) United States $1.035B 0.00
Phibro Animal Health (PAHC) United States $0.942B 12.04
InMode (INMD) Israel $0.899B 9.06
Evolus (EOLS) United States $0.624B 0.00
CeriBell (CBLL) United States $0.599B 0.00
Curaleaf Holdings (CURLF) Canada $0.569B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.565B 0.00
Valneva SE (VALN) France $0.517B 0.00
Owens & Minor (OMI) United States $0.498B 4.13
Capricor Therapeutics (CAPR) United States $0.468B 0.00
Tilray Brands (TLRY) Canada $0.445B 0.00
Surmodics (SRDX) United States $0.410B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.339B 0.00
Canopy Growth (CGC) Canada $0.336B 0.00
Cresco Labs (CRLBF) United States $0.326B 0.00
VAREX IMAGING (VREX) United States $0.310B 11.39
Aurora Cannabis (ACB) Canada $0.309B 55.00
Sanara MedTech (SMTI) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.254B 21.40
Verano Holdings (VRNOF) United States $0.248B 0.00
Sanuwave Health (SNWV) United States $0.244B 0.00
Cerus (CERS) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.231B 10.48
Brainsway (BWAY) Israel $0.203B 53.65
Biote (BTMD) United States $0.201B 5.66
OraSure Technologies (OSUR) United States $0.189B 0.00
Quanterix (QTRX) United States $0.188B 0.00
Omeros (OMER) United States $0.185B 0.00
High Tide (HITI) Canada $0.185B 0.00
Organigram Global (OGI) Canada $0.183B 0.00
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Utah Medical Products (UTMD) United States $0.175B 14.22
Exagen (XGN) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.137B 16.86
Jin Medical (ZJYL) China $0.123B 0.00
TerrAscend (TSNDF) Canada $0.119B 0.00
Agape ATP (ATPC) $0.103B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Fonar (FONR) United States $0.088B 11.30
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Veru (VERU) United States $0.073B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Jushi Holdings (JUSHF) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Apyx Medical (APYX) United States $0.058B 0.00
United Health Products (UEEC) United States $0.054B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
Modular Medical (MODD) United States $0.046B 0.00
United-Guardian (UG) United States $0.037B 12.92
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.71
Safety Shot (SHOT) United States $0.031B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00